Foghorn Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Foghorn Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Foghorn Therapeutics Inc
Rating: 1.80758325
Author: Trendlyne DVM scores

about

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, ...

5.77 0.38 (7.05%)

43.65% Fall from 52W High

110.4K

XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

5.8 / 100

Technically Moderately Bullish

66.5 / 100

1Yr Price target upside is 102%

6 analysts

Foghorn Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Foghorn Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, ...

43.65% Fall from 52W High

SWOT Analysis

Foghorn Therapeutics Inc Live Price Chart